BPC-157 vs Hexarelin
Both BPC-157 and Hexarelin are used for recovery. Here's how their evidence, dosing, and regulatory status actually compare.
BPC-157
Evidence B+Body Protection Compound-157
A 15-amino-acid peptide derived from gastric juice. The most popular recovery peptide with 100+ preclinical studies showing accelerated healing of tendons, ligaments, muscle, gut lining, and nerves.
View full BPC-157 profile →Hexarelin
Evidence BHexarelin (HEX)
The strongest GH-releasing hexapeptide and one of the few peptides with documented direct cardiac benefits in animal models. Tachyphylaxis (diminished response over time) limits long-term use.
View full Hexarelin profile →Side-by-Side
| Attribute | BPC-157 | Hexarelin |
|---|---|---|
| Evidence Grade | B+ | B |
| FDA Status | Not FDA-approved — Category 2 (reclassification to Cat 1 expected 2026) | Not FDA-approved — research compound (cardioprotective signals investigated) |
| Typical Dose | 250–500 mcg twice daily (subcutaneous) | 100 mcg, 1–2 times daily (subcutaneous) |
| Clinics Indexed | 308 | 41 |
| Categories | recovery, gut-health | growth-hormone, recovery |
Key reported benefits — BPC-157
- ✓Tendon & ligament repair
- ✓Gut healing
- ✓Muscle recovery
- ✓Neuroprotection
Key reported benefits — Hexarelin
- ✓Strongest GH spike of GHRPs
- ✓Cardioprotective signals
- ✓Recovery
Educational use only
This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.